CANU, LETIZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.670
EU - Europa 3.828
AS - Asia 3.279
SA - Sud America 604
Continente sconosciuto - Info sul continente non disponibili 170
AF - Africa 79
OC - Oceania 34
Totale 13.664
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.524
RU - Federazione Russa 1.296
IT - Italia 943
SG - Singapore 899
CN - Cina 780
PL - Polonia 581
HK - Hong Kong 518
BR - Brasile 472
VN - Vietnam 347
KR - Corea 281
IE - Irlanda 243
SE - Svezia 172
FR - Francia 112
FI - Finlandia 106
DE - Germania 100
IN - India 96
CA - Canada 92
BD - Bangladesh 86
GB - Regno Unito 82
ID - Indonesia 60
JO - Giordania 51
AR - Argentina 49
JP - Giappone 49
CH - Svizzera 37
AU - Australia 34
LU - Lussemburgo 33
MX - Messico 28
NL - Olanda 28
EC - Ecuador 27
ES - Italia 23
IQ - Iraq 23
UA - Ucraina 17
ZA - Sudafrica 17
TR - Turchia 16
CO - Colombia 15
BE - Belgio 14
MA - Marocco 14
PK - Pakistan 12
PY - Paraguay 11
CI - Costa d'Avorio 10
LT - Lituania 9
AT - Austria 8
CL - Cile 8
PE - Perù 8
PH - Filippine 8
VE - Venezuela 8
CZ - Repubblica Ceca 7
JM - Giamaica 7
NP - Nepal 7
BJ - Benin 6
UY - Uruguay 6
AE - Emirati Arabi Uniti 5
EG - Egitto 5
NG - Nigeria 5
NI - Nicaragua 5
TN - Tunisia 5
AL - Albania 4
CR - Costa Rica 4
KE - Kenya 4
KZ - Kazakistan 4
SA - Arabia Saudita 4
UZ - Uzbekistan 4
DZ - Algeria 3
LB - Libano 3
PS - Palestinian Territory 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
AM - Armenia 2
AZ - Azerbaigian 2
DO - Repubblica Dominicana 2
GE - Georgia 2
GT - Guatemala 2
HU - Ungheria 2
IR - Iran 2
KG - Kirghizistan 2
KW - Kuwait 2
MM - Myanmar 2
MY - Malesia 2
RO - Romania 2
SC - Seychelles 2
SN - Senegal 2
XK - ???statistics.table.value.countryCode.XK??? 2
AO - Angola 1
AW - Aruba 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BW - Botswana 1
BY - Bielorussia 1
DK - Danimarca 1
ET - Etiopia 1
EU - Europa 1
GR - Grecia 1
HR - Croazia 1
LI - Liechtenstein 1
LK - Sri Lanka 1
MD - Moldavia 1
MU - Mauritius 1
NA - Namibia 1
OM - Oman 1
Totale 13.492
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.131
Ashburn 829
Singapore 703
Warsaw 575
Hong Kong 460
Fairfield 377
San Jose 330
Seoul 281
Dublin 243
Hefei 231
Woodbridge 185
Milan 183
Chandler 168
Council Bluffs 162
Seattle 151
Beijing 145
Houston 145
Cambridge 140
Ho Chi Minh City 121
Wilmington 112
Ann Arbor 102
Florence 97
Moscow 95
Los Angeles 83
Altamura 79
Lawrence 78
Hanoi 75
Rome 73
Lauterbourg 68
New York 67
Buffalo 65
The Dalles 64
Princeton 60
Mumbai 51
Boston 49
Helsinki 45
Jakarta 45
Munich 45
São Paulo 39
Kent 38
Paris 37
Dallas 35
Bern 32
Shanghai 32
Melbourne 30
Phoenix 30
Tokyo 30
Lappeenranta 29
Naples 27
Toronto 26
Boardman 21
Chicago 20
Dong Ket 20
Clifton 19
Haiphong 19
Luxembourg 18
San Diego 18
Bologna 17
Brooklyn 17
Turku 17
Orem 16
Rio de Janeiro 16
Turin 16
West Jordan 16
Dudelange 15
Montreal 15
Scuola 15
Brussels 14
Genoa 14
Medford 14
Redondo Beach 14
Falls Church 13
Bengaluru 12
Frankfurt am Main 12
Da Nang 11
Guangzhou 11
Guayaquil 11
Abidjan 10
Barcelona 10
London 10
Palermo 10
Baghdad 9
Belo Horizonte 9
Chennai 9
Figino 9
Gumyojicho 9
Johannesburg 9
Mexico City 9
Poplar 9
Prato 9
Redmond 9
Atlanta 8
Brasília 8
Bremen 8
Brescia 8
Cagliari 8
Curitiba 8
Elk Grove Village 8
Jacksonville 8
Newark 8
Totale 8.921
Salva come PNG Salva come JPEG
Nome #
2D-DIGE proteomic analysis identifies new potential therapeutic targets for adrenocortical carcinoma 362
Metformin as a new anti-cancer drug in adrenocortical carcinoma 318
NEW INSIGHTS IN THE CLINICAL AND TRANSLATIONAL RELEVANCE OF miR483-5p IN ADRENOCORTICAL CANCER 307
DIAGNOSIS of ENDOCRINE DISEASE: SDHx mutations: Beyond pheochromocytomas and paragangliomas 299
S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study 248
Adrenocortical carcinoma: the dawn of a new era of genomic and molecular biology analysis. 235
DETECTION OF CIRCULATING TUMOR CELLS IN PATIENTS WITH ADRENOCORTICAL CARCINOMA: A MONOCENTRIC PRELIMINARY STUDY. 228
15 YEARS OF PARAGANGLIOMA: Metabolism and pheochromocytoma/paraganglioma 221
Fascin-1 is a Novel Prognostic Biomarker Associated with Tumor Invasiveness in Adrenocortical Carcinoma. 215
Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment 214
The aggressiveness of succinate dehydrogenase subunit B-deficient chromaffin cells is reduced when their bioelectrical properties are restored by glibenclamide 207
Glutaminases as a Novel Target for SDHB-Associated Pheochromocytomas/Paragangliomas. 203
The role of PPAR-γ system in normal and tumoral corticotroph pituitary and adrenal cells. 201
Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study 197
Morphofunctional effects of mitotane on mitochondria in human adrenocortical cancer cells. 192
Hypogonadism and sexual function in men affected by adrenocortical carcinoma under mitotane therapy 190
Management of adrenocortical carcinoma: a consensus statement of the Italian Society of Endocrinology (SIE). 189
[68Ga]DOTATOC PET-derived radiomics to predict genetic background of head and neck paragangliomas: a pilot investigation 187
Analysis of circulating extracellular vesicle-associated microRNAs in cortisol-producing adrenocortical tumors 186
Sunitinib in the therapy of malignant paragangliomas: Report on the efficacy in a sdhb mutation carrier and review of the literature 186
A multicenter epidemiological study on second malignancy in non-syndromic pheochromocytoma/paraganglioma patients in Italy 185
Novel Somatic Mutations in the Catalytic Subunit of the Protein Kinase A as a Cause of Adrenal Cushing's Syndrome: A European Multicentric Study. 184
Co-occurrence of mutations in NF1 and other susceptibility genes in pheochromocytoma and paraganglioma 183
SDHx and Non-Chromaffin Tumors: A Mediastinal Germ Cell Tumor Occurring in a Young Man with Germline SDHB Mutation 183
Caratterizzazione genomica del carcinoma surrenalico 182
Case Report: Adrenocortical Oncocytoma in a Patient with a Previous Contralateral Adrenalectomy for a Cortisol-Secreting Adenoma 180
Hemodynamic parameters in patients undergoing surgery for pheochromocytoma/paraganglioma: a retrospective study 179
Mitochondrial function and content in Pheochromocytoma/paraganglioma of succinate dehydrogenase mutation carriers 176
Novel Germline PHD2 Variant in a Metastatic Pheochromocytoma and Chronic Myeloid Leukemia, but in the Absence of Polycythemia 173
Carbonic anhydrases III and IX are new players in the crosstalk between adrenocortical carcinoma and its altered adipose microenvironment 171
Targeted Next Generation Sequencing molecular profiling and its clinical application in adrenocortical cancer 171
Role of microenvironment on neuroblastoma SK-N-AS SDHB-silenced cell metabolism and function 171
Tumour microenvironment in pheochromocytoma and paraganglioma 170
The 3D in vitro Adrenoid cell model recapitulates the complexity of the adrenal gland 170
The microenvironment induces collective migration in SDHB-silenced mouse pheochromocytoma spheroids 170
Germline Mutation in KIF1Bβ Gene Associated with Loss of Heterozygosity: Usefulness of Next-Generation Sequencing in the Genetic Screening of Patients with Pheochromocytoma 170
New Findings on Presentation and Outcome of Patients With Adrenocortical Cancer: Results From a National Cohort Study 167
Intratumour microbiota modulates adrenocortical cancer responsiveness to mitotane 165
Ipertensione ed esercizio fisico 165
Outcomes of adrenal-sparing surgery or total adrenalectomy in phaeochromocytoma associated with multiple endocrine neoplasia type 2: an international retrospective population-based study. 163
Prognostic and monitoring value of circulating tumour cells in adrenocortical carcinoma: a preliminary monocentric study. 163
Integrative multi-omics analysis identifies a prognostic miRNA signature and a targetable miR-21-3p/TSC2/ mTOR axis in metastatic pheochromocytoma/ paraganglioma 162
Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective study 161
Circulating Fascin 1 as a Promising Prognostic Marker in Adrenocortical Cancer 159
Feocromocitoma/Paraganglioma: aspetti radiologici ed associazione con seconde neoplasie. 158
Stimulated expression of CXCL12 in adrenocortical carcinoma by the ppargamma ligand rosiglitazone impairs cancer progression 158
Management and outcome of metastatic pheochromocytomas/paragangliomas: a monocentric experience 158
Adrenocortical carcinoma: Current treatment options 157
Analysis of telomere maintenance related genes reveals NOP10 as a new metastatic-risk marker in pheochromocytoma/paraganglioma 155
Prognosis of malignant pheochromocytoma and paraganglioma (MAPP-PronO study): A European network for the study of adrenal tumors retrospective study 154
Prognostic Value of Microscopic Tumor Necrosis in Adrenal Cortical Carcinoma 154
Outcome and genetic analysis of patients affected by retinal capillary hemangioblastoma in von hippel lindau syndrome 153
What Is the Optimal Duration of Adjuvant Mitotane Therapy in Adrenocortical Carcinoma? An Unanswered Question 150
Cancer-testis Antigen FATE1 Expression in Adrenocortical Tumors Is Associated with A Pervasive Autoimmune Response and Is A Marker of Malignancy in Adult, but Not Children, ACC 149
SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: A multicenter interobserver variation analysis using virtual microscopy: A Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T) 148
Impact of 123I-MIBG Scintigraphy on Clinical Decision-Making in Pheochromocytoma and Paraganglioma 148
[Arterial hypertension and RU-486: a complex case of secondary hypertension] 147
Urine steroid metabolomics as a novel tool for detection of recurrent adrenocortical carcinoma 145
Metodiche di dosaggio di metanefrine e catecolamine: rischi e variabili interpretative per i dosaggi effettuati in centri non specializzati 143
ENSAT Registry-Based Randomized Clinical Trials for Adrenocortical Carcinoma 138
Potential pitfalls of SDH immunohistochemical detection in paragangliomas and phaeochromocytomas harbouring germline SDHx gene mutation 138
Phase II study of cabazitaxel as second-third line treatment in patients with metastatic adrenocortical carcinoma 137
Management and outcome of metastatic pheochromocytomas/paragangliomas: an overview 136
Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study 134
Unenhanced CT imaging is highly sensitive to exclude pheochromocytoma: a multicenter study 133
Current clinical practice for thromboprophylaxis management in patients with Cushing’s syndrome across reference centers of the European Reference Network on Rare Endocrine Conditions (Endo-ERN) 132
Mass spectrometry imaging identifies metabolic patterns associated with malignant potential in pheochromocytoma and paraganglioma 129
Anatomical and functional changes of the fetal adrenal gland in intrauterine growth restriction 128
Pitfalls in Genetic Analysis of Pheochromocytomas/Paragangliomas-Case Report. 127
MAML3-fusions modulate vascular and immune tumour microenvironment and confer high metastatic risk in pheochromocytoma and paraganglioma 126
Malignant Pheochromocytoma 122
Pheochromocytomas and paragangliomas as causes of endocrine hypertension 114
Pros and cons of surgical versus conservative management for head and neck paraganglioma: a real-world data analysis 110
Use and utility of endocrine multidisciplinary tumour board: an appraisal from a tertiary centre 108
The penetrance of MEN2 pheochromocytoma is not only determined byRETmutations 98
High Filamin a Expression in Adrenocortical Carcinomas Is Associated with a Favourable Tumour Behaviour: A European Multicentric Study 91
Emerging role of IGF1R and IR expression and localisation in adrenocortical carcinomas 90
Volumetric evaluation of CT images of adrenal glands in primary aldosteronism 89
Hypertension and Cushing’s syndrome: hunt for the red flag 85
In-depth Genetic and Molecular Characterization of Unilateral Coexisting Adrenal Cortical Adenoma and Carcinoma in the Context of MEN1 Syndrome 65
Presurgical Succinate MetAstatic Risk Tool (P-SMART) in Paragangliomas 52
An innovative nuclear antigen-based approach for single-cell isolation of circulating tumor cells in adrenal cortical carcinoma 51
Systematic review of multimodal management strategies for Insulinoma-Induced hypoglycaemia: current evidence and future directions. 36
Clinical Predictors of Outcome in Advanced Adrenocortical Carcinoma: a multicentre international ENSAT study 34
Hypogonadism and sexual function in men affected by adrenocortical carcinoma under mitotane therapy. 27
Multicentric Retrospective Analysis of Oncocytic Adrenocortical Carcinoma: Insights into Clinical and Management Strategies 27
Mechanical Circulatory Support in Paraganglioma Induced Cardiogenic Shock and Intestinal Ischemia: Lessons from a Complex Case and Narrative Review 22
Totale 13.664
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.283
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.283
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022358 0 0 26 34 21 24 10 59 17 24 32 111
2022/20231.000 95 238 41 59 48 149 148 39 106 18 22 37
2023/2024619 11 47 87 29 49 99 19 109 33 66 52 18
2024/20253.792 116 384 226 634 920 476 103 336 104 119 178 196
2025/20265.186 510 726 499 540 506 184 532 231 302 391 203 562
2026/2027553 205 118 230 0 0 0 0 0 0 0 0 0
Totale 13.664